Webinar: Lessons Learned from the 2025 External Quality Assessment (EQA) Scheme for Molecular Testing in Lung Cancer Liquid Biopsy Samples

We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.

Click here for more information on cookies, including how to remove them.

Accept Cookies

8th October 2026

Thursday 8 October 2026 | 12:00–13:00 BST

Join us for a one-hour webinar exploring key learnings from the 2025 External Quality Assessment (EQA) Scheme for molecular testing in lung cancer liquid biopsy samples.

Organised and funded by AstraZeneca, this webinar brings together expertise from across the molecular diagnostics community, with Dr Sandi Deans, Director of GenQA, and Dr Simon Patton, Chief Executive of EMQN CIC, sharing insights from recent EQA activity.

The session will provide an opportunity to reflect on key learnings, share best practice and support continued quality improvement in molecular testing.

Who should attend?
This webinar is intended for clinical scientists, molecular pathologists, oncologists and EQA scheme participants.

Agenda

12:00 – Welcome and introductions
12:05 – Key learnings from the 2025 EQA Scheme for liquid-based molecular testing in lung cancer
12:45 – Questions and answers

This is a non-promotional webinar organised and funded by AstraZeneca.

Register for the webinar: Here

Follow GenQA on LinkedIn to stay up to date with the latest information.

<< BACK

Events